SASSO, Ferdinando Carlo
 Distribuzione geografica
Continente #
EU - Europa 16.005
NA - Nord America 6.983
AS - Asia 6.933
SA - Sud America 1.056
AF - Africa 96
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 5
Totale 31.088
Nazione #
RU - Federazione Russa 11.030
US - Stati Uniti d'America 6.842
SG - Singapore 2.284
CN - Cina 1.508
IE - Irlanda 1.353
IT - Italia 1.200
VN - Vietnam 1.053
HK - Hong Kong 1.030
BR - Brasile 884
DE - Germania 522
GB - Regno Unito 516
UA - Ucraina 410
KR - Corea 301
IN - India 265
SE - Svezia 217
FR - Francia 206
FI - Finlandia 151
JP - Giappone 139
TR - Turchia 101
GR - Grecia 98
NL - Olanda 74
AR - Argentina 69
CA - Canada 68
MX - Messico 46
AT - Austria 38
CZ - Repubblica Ceca 36
ID - Indonesia 35
BD - Bangladesh 32
PL - Polonia 30
ZA - Sudafrica 28
IQ - Iraq 27
EC - Ecuador 26
BE - Belgio 24
ES - Italia 22
PK - Pakistan 18
VE - Venezuela 18
CO - Colombia 17
MA - Marocco 16
LT - Lituania 14
EG - Egitto 13
IR - Iran 13
UZ - Uzbekistan 12
CH - Svizzera 11
DK - Danimarca 11
IL - Israele 11
PY - Paraguay 11
SA - Arabia Saudita 11
PE - Perù 10
UY - Uruguay 10
AU - Australia 9
MY - Malesia 9
PT - Portogallo 9
SC - Seychelles 9
TN - Tunisia 9
AE - Emirati Arabi Uniti 8
JO - Giordania 8
CL - Cile 7
AZ - Azerbaigian 6
NP - Nepal 6
OM - Oman 6
RO - Romania 6
EU - Europa 5
GE - Georgia 5
JM - Giamaica 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
BH - Bahrain 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
KE - Kenya 4
KG - Kirghizistan 4
LB - Libano 4
SI - Slovenia 4
TH - Thailandia 4
BO - Bolivia 3
CR - Costa Rica 3
CY - Cipro 3
DZ - Algeria 3
EE - Estonia 3
HN - Honduras 3
KW - Kuwait 3
NG - Nigeria 3
PH - Filippine 3
RS - Serbia 3
AL - Albania 2
AM - Armenia 2
BB - Barbados 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
HR - Croazia 2
HU - Ungheria 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
MO - Macao, regione amministrativa speciale della Cina 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
AN - Antille olandesi 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
Totale 31.069
Città #
Moscow 4.007
Dublin 1.324
Singapore 1.069
Hong Kong 998
San Jose 848
Santa Clara 771
Chandler 692
Jacksonville 622
Ashburn 346
Ho Chi Minh City 341
Dallas 309
The Dalles 306
Hefei 291
Seoul 290
Naples 250
Hanoi 248
Bengaluru 189
Beijing 188
Princeton 176
New York 174
Medford 132
Munich 130
Roxbury 121
Ann Arbor 108
Bremen 101
Los Angeles 95
Boardman 90
São Paulo 82
Wilmington 82
Caserta 72
Woodbridge 72
Da Nang 67
San Mateo 65
Nanjing 63
Haiphong 57
Cambridge 54
Orem 49
Amsterdam 43
Des Moines 42
Aversa 36
Falkenstein 31
Frankfurt am Main 31
Houston 31
Rome 30
Düsseldorf 29
Milan 29
Napoli 29
Rio de Janeiro 29
Salerno 29
Helsinki 27
Chicago 26
Jinan 26
Mountain View 26
Tianjin 26
Tokyo 25
Brussels 24
Ercolano 24
Chennai 23
Hải Dương 22
Nuremberg 22
Kunming 21
Council Bluffs 20
Montreal 20
Biên Hòa 19
Bắc Ninh 19
Istanbul 19
Mexico City 19
Shanghai 19
Turku 19
Atlanta 18
Brooklyn 18
Changsha 18
Shenyang 18
Belo Horizonte 17
Brno 17
London 17
Vienna 17
Seattle 16
Stockholm 16
Boston 15
Brasília 15
Hillsboro 15
Nanchang 15
Norwalk 15
Ottawa 15
Warsaw 15
Giugliano In Campania 14
Paris 14
Lappeenranta 13
Porto Alegre 13
Thái Bình 13
Zhengzhou 13
Florence 12
Guangzhou 12
Nha Trang 12
Thái Nguyên 12
Haikou 11
Johannesburg 11
Manchester 11
Redwood City 11
Totale 16.163
Nome #
Microplastics and Nanoplastics in Atheromas and Cardiovascular Events 317
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 222
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 215
A Multicenter, Open-Label Phase II Study of Metformin With Erlotinib in Second-Line Therapy of Stage IV Non-Small-Cell Lung Cancer Patients: Treatment Rationale and Protocol Dynamics of the METAL Trial. 204
Autonomic dysfunction is associated with brief episodes of atrial fibrillation in type 2 diabetes. 201
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 195
Microbiota thrombus colonization may influence athero-thrombosis in hyperglycemic patients with ST segment elevation myocardialinfarction (STEMI). Marianella study 185
Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study 183
Endocan Serum Levels in Patients with Non-Alcoholic Fatty Liver Disease with or without Type 2 Diabetes Mellitus: A Pilot Study 181
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 181
Aminotrasferase activity and acarbose treatment in patients with type 2 diabetes 180
Acute effects of beta-endorphin on cardiovascular function in patients with mild to moderate chronic heart failure 180
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 179
MiRNA regulation of the hyperproliferative phenotype of vascular smooth muscle cells in diabetes 178
Acute pressor and hormonal effects of beta-endorphin at high doses in healthy and hypertensive subjects: role of opioid receptor agonism. 177
Non-invasive respiratory support in SARS-CoV-2 related acute respiratory distress syndrome: when is it most appropriate to start treatment? 175
[Surgical treatment and interventional therapy in cerebral ischemia] 175
Carbonic anhydrase activation is associated with worsened pathological remodeling in human ischemic diabetic cardiomyopathy 169
Cardiovascular risk factors and disease management in type 2 diabetic patients with diabetic nephropathy 164
Effect of treatment with acarbose and insulin in patients with non-insulin-dependent diabetes mellitus associated with non-alcoholic liver cirrhosis 164
Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease 162
Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes: insights from the multicenter START-ANTIPLATELET registry 161
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors 161
Bipolar Patients and Bullous Pemphigoid after Risperidone Long-Acting Injectable: A Case Report and a Review of the Literature 157
Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC 156
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 155
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 155
IMPACT OF TYPE II DIABETES ON HCC APPEARANCE IN PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS 153
HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis 152
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study 152
esults from a prospective observational study of men with premature ejaculation treated with dapoxetine or alternative care: the PAUSE study. 152
EFFECT OFTREATMENT WITH ACARBOSE,AN A-GLUCOSIDASE INHIBITOR ANDINSULIN IN PATIENT WITH NON-INSULIN-DEPENDENTDIABETESMELLITUS NON ALCOLIC LIVER CIRRHOSIS 152
Aspirin in a Diabetic Retinopathy Setting: insights from NO BLIND Study 152
Brief episodes of silent atrial fibrillation predict clinical vascular brain disease in type 2 diabetic patients 151
Factors affecting long-term changes of liver stiffness in direct-acting anti-hepatitis C virus therapy: a multicenter prospective study 151
Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19 151
Glycated ACE2 reduces anti-remodeling effects of renin-angiotensin system inhibition in human diabetic hearts 150
Aminotransferase activity and acarbose treatment in patients with type 2 diabetes 150
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 150
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 149
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 149
Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies 148
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 148
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 147
Amelanotic metastatic melanoma of the stomach presenting with iron deficiency anemia 147
Pre-Menopausal Breast Fat Density Might Predict MACE During 10 Years of Follow-Up: The BRECARD Study 146
[Inhibitors of the platelet's receptor GPIIb/IIIA. Progress in the treatment of acute myocardial ischemia and future trends] 144
Metformin therapy effects on the expression of sodium-glucose cotransporter 2, leptin, and sirt6 levels in pericoronary fat excised from pre-diabetic patients with acute myocardial infarction 144
Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects? 143
The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques: Effects of rosiglitazone treatment 142
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives 140
Effect of a single high-fat meal on endothelial function in patients with the metabolic syndrome: Role of tumor necrosis factor-alpha 139
Relevance of lung ultrasound in the diagnostic algorithm of respiratory diseases in a real-life setting: A multicentre prospective study 139
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 138
Left bundle branch pacing and cardiac remodeling in HF patients with type 2 diabetes mellitus: epigenetic pathways and clinical outcomes 138
Glucose metabolism and coronary heart disease in patients with normal glucose tolerance. 138
Clinical application of lung ultrasound score on COVID-19 setting: a regional experience in Southern Italy 138
Comment on: Effect of Vitamin D supplementation in patients with liver cirrhosis having spontaneous bacterial peritonitis: a randomized controlled study 138
Disfunzione renale nell’anziano: processo fisiologico o malattia? 137
Effects of stress hyperglicemia on acute myocardial infarction 136
Adapting the GLP-1-signaling system to the treatment of type 2 diabetes 136
Predictors of early and late hepatocellular carcinoma recurrence 135
Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era? 135
Innate immune activity in plaque of patients with untreated and L-thyroxine-treated subclinical hypothyroidism. 135
Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome 135
Long-Term Prognosis among COVID-19 Patients: The Predictive Role Played by Hyperinflammation and Arrhythmic Disorders in Fatal Outcome 134
Cardiovascular benefits from gliflozins: Effects on endothelial function 134
Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment 134
HCC and molecular targeting therapies: Back to the future 133
Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma 132
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 131
Multi-detector row CT for depicting anatomic features of cephalothoracopagus varieties: revised approach 131
A case of autoimmune polyglandular syndrome developed after interferon-alpha therapy 131
Effect of Body Mass Index on Ischemic and Bleeding Events in Patients Presenting With Acute Coronary Syndromes (from the START-ANTIPLATELET Registry) 131
An Update on Betrixaban, the Challenging Anticoagulant Agent for Extended Venous Thromboembolism Prophylaxis 130
Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels 130
High cardiovascular risk in patients with Type 2 diabetic nephropathy: the predictive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort Study. 130
Effects of Sodium-Glucose Transporter 2 Inhibitors (SGLT2-I) in Patients With Ischemic Heart Disease (IHD) Treated by Coronary Artery Bypass Grafting via MiECC: Inflammatory Burden, and Clinical Outcomes at 5 Years of Follow-Up 130
Sodium-Glucose Co-Transporters Family: Current Evidence, Clinical Applications and Perspectives 129
Dipeptidyl peptidase 4 inhibition may facilitate healing of chronic foot ulcers in patients with type 2 diabetes. 129
Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination 128
Prescription of ACE-Is/ARBs in patients with cardio-renal disease: a multicenter retrospective cohort study from the REPOSI registry 128
Liver Involvement in Patients With Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis 128
Tight Glycemic Control May Increase Regenerative Potential of Myocardium during Acute Infarction. 128
Blocco di branca sinistra in lavoratori sottoposti a movimentazione manuale di carichi con basso rischio di patologie cardiache: applicazione della tomografia computerizzata multistrato 128
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 127
LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: results from the "LOWERING-IT" Trial. 127
Effect of rosiglitazone on endothelial function and inflammatory markers in patients with the metabolic syndrome 127
Precoce evidenziazione della nefropatia diabetica mediante scìntigrafia renale con 99-Tc DTPA 127
A case of anaplastic thyroid carcinoma with exceptional growth. 127
Autonomic nervous system dysfunction correlates with microvascular damage in systemic sclerosis patients 127
Comment on: Warfarin adherence and anticoagulation control in atrial fibrillation patients-a systematic review 127
Could Ghrelin Expression Regulate Diastolic Cardiac Function in Type 2 Diabetic Obese Patients? 126
Multiparametric correlation of laboratory biomarkers to multiorgan failure outcome in hospitalized COVID-19 patients: a retrospective observational study 126
Metabolic dysfunction-associated steatotic liver disease (MASLD): a systemic disease with a variable natural history and challenging management 126
Effect of insulin on left ventricular function during dynamic exercise in overweight and obese subjects 126
Genetic predictors of response to treatment of chronic hepatitis C virus infection in patients from southern Italy 126
Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct‐acting antivirals 126
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 126
The possible role of the ubiquitin proteasome system in the development of atherosclerosis in diabetes 125
Totale 14.917
Categoria #
all - tutte 101.395
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.395


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021311 0 0 0 0 0 0 0 0 0 125 135 51
2021/20221.326 94 11 28 60 421 29 32 36 70 108 108 329
2022/20232.682 222 75 62 213 291 225 12 164 1.255 44 58 61
2023/20241.450 117 77 74 129 377 170 21 50 19 71 123 222
2024/20254.354 45 85 37 115 640 477 627 377 689 478 398 386
2025/202618.828 826 1.064 1.111 819 1.597 10.255 1.240 801 719 396 0 0
Totale 31.600